Alzamend Neuro (ALZN) Depreciation and Depletion (2022 - 2026)
Alzamend Neuro's Depreciation and Depletion was $27,685 in fiscal Q1 2027 (quarter ended Jul 31, 2026), unchanged from $27,685 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Depreciation and Depletion (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alzamend Neuro's Depreciation and Depletion was $110,740 through Jul 31, 2026, up 68.5% year-over-year; for FY2026 (ended Apr 30, 2026), it was $110,740, up 118.2% from FY2025.
- Depreciation and Depletion shows a four-year compound annual growth rate of 136.3% (FY2022 to FY2026).
- In earlier fiscal years, Depreciation and Depletion was $50,740 in FY2025 (unchanged), $50,740 in FY2024 (+120.0%), $23,066 in FY2023 (+549.9%) and $3,549 in FY2022.
- Compared with a year earlier, Depreciation and Depletion was higher in four of the last eight quarters, with growth averaging 59.1%.
- Over the past five years, the year-over-year growth in Depreciation and Depletion ranged from 0.0% (fiscal Q1 2025) to 138.3% (fiscal Q4 2024).
- Per Business Quant data, ALZN's Depreciation and Depletion in the three fiscal quarters before Q1 2027 was $27,685 (Q4 2026), $27,685 (Q3 2026) and $27,685 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | 27,685.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 27,685.00 |
| Apr 30, 2026 | 27,685.00 |
| Jan 31, 2026 | 27,685.00 |
| Oct 31, 2025 | 27,685.00 |
| Jul 31, 2025 | 27,685.00 |
| Apr 30, 2025 | 12,685.00 |
| Jan 31, 2025 | 12,685.00 |
| Oct 31, 2024 | 12,685.00 |
| Jul 31, 2024 | 12,685.00 |
| Apr 30, 2024 | 12,685.00 |
| Jan 31, 2024 | 12,685.00 |
| Oct 31, 2023 | 12,685.00 |
| Jul 31, 2023 | 12,685.00 |
| Apr 30, 2023 | 5,323.00 |
| Jan 31, 2023 | 5,323.00 |
| Oct 31, 2022 | 5,323.00 |
| Jul 31, 2022 | 7,097.00 |
API Access
Alzamend Neuro Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();